National Institutes of Health: all 11,571 studies

Page 110 of 116. Open to participants first (945), then studies with results posted, then the rest; newest registration first within each.

• A Study of AL721 in HIV-Infected Patients With Swollen Lymph NodesCompletedNCT00001012Phase 1
• The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related ComplexCompletedNCT00001011Phase 3
• A Study of Zidovudine Plus Acyclovir in HIV-Infected PatientsCompletedNCT00001010Phase 1
• A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC)CompletedNCT00001009Phase 1
• A Study of Azidothymidine Plus Methadone in Patients With AIDS and AIDS Related Complex (ARC)CompletedNCT00001008Not applicable
• A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After BirthCompletedNCT00001007Phase 1
• A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC)CompletedNCT00001006Phase 1
• A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph NodesCompletedNCT00001005Phase 1
• A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related ComplexCompletedNCT00001004Phase 2
• A Study of Pentamidine in the Prevention of Pneumocystis Carinii PneumoniaCompletedNCT00001003Not applicable
• A Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long TimeCompletedNCT00001002Phase 1
• A Study of Zidovudine in HIV-Infected Patients With Liver DiseaseCompletedNCT00001001Not applicable
• A Study of Atvogen in Healthy Volunteers and HIV-Infected Patients Who Have No Symptoms of InfectionCompletedNCT00001000Not applicable
• The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARCCompletedNCT00000999Phase 1
• A Study of Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Not Previously Treated for PCPCompletedNCT00000998Phase 1
• A Study of Dideoxycytidine in HIV-Infected PatientsCompletedNCT00000997Not applicable
• A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's SarcomaCompletedNCT00000996Phase 2
• A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) InfectionCompletedNCT00000995Not applicable
• A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00000994Phase 3
• A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the VirusCompletedNCT00000993Not applicable
• A Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in Patients With AIDSCompletedNCT00000992Phase 1
• A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected PatientsCompletedNCT00000991Phase 3
• The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate SymptomsCompletedNCT00000990Phase 2
• The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDSCompletedNCT00000989Not applicable
• A Study of BMY-27857 in Patients With AIDS or AIDS Related ComplexCompletedNCT00000988Phase 1
• A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDSCompletedNCT00000987Phase 1
• The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related ComplexCompletedNCT00000986Phase 1
• Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With AcyclovirCompletedNCT00000985Phase 3
• A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV InfectionCompletedNCT00000984Phase 1
• The Safety of Different Dose Levels of Zidovudine in HIV-Infected ChildrenCompletedNCT00000983Phase 2
• A Study of Azidothymidine in HIV-Infected ChildrenCompletedNCT00000982Phase 2
• The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus (CMV) in Patients With AIDSCompletedNCT00000981Phase 2
• Comparison of ddI Versus Zidovudine in HIV-Infected PatientsCompletedNCT00000979Phase 2
• A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced AIDS Related Complex (ARC)CompletedNCT00000978Phase 1
• Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and ToxicityCompletedNCT00000977Phase 1
• A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related ComplexCompletedNCT00000976Phase 1
• A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDSCompletedNCT00000975Phase 2
• A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii PneumoniaCompletedNCT00000974Phase 1
• A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive PatientsCompletedNCT00000973Phase 1
• A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59CompletedNCT00000972Phase 1
• A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With GanciclovirCompletedNCT00000970Phase 1
• A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) TherapyCompletedNCT00000969Not applicable
• A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived HIV-1 Recombinant Envelope Glycoprotein (gp160)CompletedNCT00000968Phase 1
• The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected ChildrenCompletedNCT00000967Phase 1
• The Effects of Zidovudine on the Blood of HIV-Infected PatientsCompletedNCT00000965Not applicable
• The Effect of Stomach Acid on FoscarnetCompletedNCT00000964Phase 1
• A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take ZidovudineCompletedNCT00000963Phase 2
• The Safety and Effectiveness of BI-RG-587 in HIV-Infected PatientsCompletedNCT00000962Phase 1
• The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected InfantsTerminatedNCT00000961Phase 2
• The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their InfantsCompletedNCT00000960Phase 3
• Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous InfectionCompletedNCT00000959Not applicable
• A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)CompletedNCT00000958Phase 1
• A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated SchedulesCompletedNCT00000957Phase 1
• A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160CompletedNCT00000956Phase 1
• Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) InfectionCompletedNCT00000955Not applicable
• A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's SarcomaCompletedNCT00000954Phase 1
• Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected PatientsCompletedNCT00000953Phase 2
• A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and ChildrenCompletedNCT00000952Phase 1
• A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent ThrushCompletedNCT00000951Phase 4
• Metabolism of Antituberculosis Drugs in HIV-Infected Persons With TuberculosisCompletedNCT00000950Not applicable
• A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3CompletedNCT00000949Phase 3
• Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3CompletedNCT00000948Phase 2
• A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive PatientsCompletedNCT00000947Not applicable
• A Study to Test the Safety of Three Experimental HIV VaccinesCompletedNCT00000946Phase 1
• A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS PatientsCompletedNCT00000945Not applicable
• A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their InfantsCompletedNCT00000944Phase 1
• A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328CompletedNCT00000943Not applicable
• A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their BabiesCompletedNCT00000942Phase 3
• A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your BloodCompletedNCT00000941Phase 1
• Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIVCompletedNCT00000940Phase 2
• A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as PossibleCompletedNCT00000939Phase 2
• A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme DiseaseCompletedNCT00000938Phase 3
• Study and Treatment of Post Lyme Disease (STOP-LD)CompletedNCT00000937Phase 3
• A Study To Test An Anti-Rejection Therapy After Kidney TransplantationTerminatedNCT00000936Phase 3
• An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant AntigensCompletedNCT00000935Phase 3
• Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048CompletedNCT00000933
• A Study of the Long-Term Outcomes of HIV-Positive PatientsCompletedNCT00000932
• HIV Prevention Counseling for Men Who Have Sex With MenCompletedNCT00000931Phase 3
• A Study of HIV in Newly Infected IndividualsCompletedNCT00000930
• A Study of the Effects of Advantage 24 on the RectumCompletedNCT00000929Phase 1
• Phase I Trial of an Intervention to Increase Condom Use by HIV-Discordant CouplesCompletedNCT00000928Phase 1
• A Study of BufferGel in WomenCompletedNCT00000927Phase 1
• A Study of Nonoxynol-9 (N-9) and HIV InfectionCompletedNCT00000926Phase 3
• A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight LossCompletedNCT00000925Phase 2
• A Study to Compare Two Different Anti-HIV Drug RegimensCompletedNCT00000924Phase 2
• Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328CompletedNCT00000923Not applicable
• A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)CompletedNCT00000922Not applicable
• The Effects of Prednisone on HIV Levels and the Immune SystemCompletedNCT00000921Phase 2
• Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their NewbornsCompletedNCT00000920Phase 1
• A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV InfectionCompletedNCT00000919Not applicable
• A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment FailureCompletedNCT00000918Phase 2
• Setting up a Blood Bank for Gene Therapy in HIV-Infected InfantsTerminatedNCT00000917
• A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their BloodCompletedNCT00000916Phase 2
• An HIV Vaccine Preparedness StudyCompletedNCT00000915Not applicable
• A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 WeeksCompletedNCT00000914Not applicable
• A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive ChildrenCompletedNCT00000913Phase 2
• A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive PatientsCompletedNCT00000912Phase 2
• A Study to Monitor Patients With Primary or Early HIV InfectionCompletedNCT00000911
• A Study to Collect Information About HIV-Positive Pregnant Women and Their BabiesCompletedNCT00000910
• A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV TherapyCompletedNCT00000909Phase 2

← National Institutes of Health overview and focus areas